Piper Sandler Has Lowered Expectations for Hercules Capital (NYSE:HTGC) Stock Price

Key Points

• Piper Sandler cut its price target on Hercules Capital from $17.50 to $16.50 and kept a "neutral" rating, while MarketBeat's consensus remains a Moderate Buy with an average target of $18.54.
• Hercules faces heightened near‑term risk as multiple plaintiff law firms and Hagens Berman allege disclosure and deal‑sourcing issues, prompting securities class‑action notices that have increased selling pressure.
• The business showed positive operational signs with a record $1.81 billion of new debt and equity commitments in Q1, and insiders (including CEO Scott Bluestein) recently bought shares, modestly increasing insider ownership.

Hercules Capital (NYSE:HTGC - Get Free Report) had its price objective reduced by stock analysts at Piper Sandler from $17.50 to $16.50 in a note issued to investors on Tuesday,Benzinga reports. The firm presently has a "neutral" rating on the financial services provider's stock. Piper Sandler's price target suggests a potential upside of 9.51% from the company's previous close.

Several other equities research analysts also recently commented on the company. Wells Fargo & Company reduced their target price on Hercules Capital from $18.00 to $17.00 and set an "overweight" rating for the company in a report on Friday, February 13th. Wall Street Zen lowered Hercules Capital from a "buy" rating to a "hold" rating in a research report on Saturday, December 20th. Lucid Cap Mkts raised Hercules Capital to a "strong-buy" rating in a research report on Monday, December 15th. Capital One Financial set a $19.75 price target on Hercules Capital in a research report on Monday, December 15th. Finally, Keefe, Bruyette & Woods dropped their price target on Hercules Capital from $20.00 to $19.00 and set an "outperform" rating on the stock in a research report on Friday, February 13th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, Hercules Capital has a consensus rating of "Moderate Buy" and an average target price of $18.54.

Hercules Capital Trading Down 0.7%

Shares of NYSE HTGC traded down $0.11 during mid-day trading on Tuesday, hitting $15.07. 683,279 shares of the company traded hands, compared to its average volume of 2,630,730. Hercules Capital has a 1 year low of $13.70 and a 1 year high of $19.67. The stock has a market capitalization of $2.77 billion, a price-to-earnings ratio of 8.23 and a beta of 0.83. The company has a quick ratio of 1.48, a current ratio of 1.48 and a debt-to-equity ratio of 1.03. The business has a 50 day moving average of $15.46 and a two-hundred day moving average of $17.28.

Hercules Capital (NYSE:HTGC - Get Free Report) last announced its earnings results on Thursday, February 12th. The financial services provider reported $0.48 EPS for the quarter, meeting the consensus estimate of $0.48. Hercules Capital had a return on equity of 15.97% and a net margin of 63.80%.The business had revenue of $133.25 million during the quarter, compared to the consensus estimate of $141.57 million. During the same period in the prior year, the business posted $0.49 earnings per share. On average, sell-side analysts anticipate that Hercules Capital will post 1.96 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, CEO Scott Bluestein bought 30,000 shares of the company's stock in a transaction on Tuesday, February 24th. The shares were bought at an average cost of $15.08 per share, with a total value of $452,400.00. Following the transaction, the chief executive officer directly owned 2,509,379 shares in the company, valued at approximately $37,841,435.32. This trade represents a 1.21% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Thomas J. Fallon bought 20,000 shares of the company's stock in a transaction on Tuesday, February 17th. The stock was purchased at an average cost of $15.88 per share, for a total transaction of $317,600.00. Following the completion of the transaction, the director owned 120,369 shares in the company, valued at approximately $1,911,459.72. The trade was a 19.93% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders acquired 117,015 shares of company stock worth $1,749,620. Insiders own 1.80% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Marshall Wace LLP acquired a new position in shares of Hercules Capital during the 3rd quarter valued at about $11,199,000. Qube Research & Technologies Ltd increased its holdings in shares of Hercules Capital by 425.6% during the 2nd quarter. Qube Research & Technologies Ltd now owns 580,414 shares of the financial services provider's stock valued at $10,610,000 after acquiring an additional 469,989 shares during the last quarter. UBS Group AG increased its holdings in shares of Hercules Capital by 26.8% during the 4th quarter. UBS Group AG now owns 1,671,860 shares of the financial services provider's stock valued at $31,464,000 after acquiring an additional 353,092 shares during the last quarter. Muzinich & Co. Inc. increased its holdings in shares of Hercules Capital by 34.5% during the 4th quarter. Muzinich & Co. Inc. now owns 1,335,787 shares of the financial services provider's stock valued at $25,140,000 after acquiring an additional 342,967 shares during the last quarter. Finally, HRT Financial LP increased its holdings in shares of Hercules Capital by 100.9% during the 2nd quarter. HRT Financial LP now owns 558,010 shares of the financial services provider's stock valued at $10,200,000 after acquiring an additional 280,198 shares during the last quarter. 19.69% of the stock is owned by institutional investors and hedge funds.

Hercules Capital News Roundup

Here are the key news stories impacting Hercules Capital this week:

• Positive Sentiment: Hercules reported a record $1.81 billion of new debt and equity commitments in Q1, a business update that supports growth and earnings prospects and helps explain recent investor interest. BusinessWire: Hercules Capital Sets New Record
• Positive Sentiment: Recent market commentary and session performance showed HTGC briefly outperforming peers—reflecting investor focus on the company’s portfolio momentum and dividend yield. Yahoo Finance: Hercules Capital Outpaces Market
• Neutral Sentiment: Analyst/independent writeups flag HTGC as attractively valued with a high yield and some insider buying, but they stress “massive caveats” tied to sector exposure and portfolio concentration—mixed for investor risk/return. Seeking Alpha: Hercules Capital - Cheap With Massive Caveats
• Neutral Sentiment: Broader financial sector moves provided context for short‑term trading but are not the primary driver; sector trends can amplify HTGC’s swings given its REIT/credit profile. Yahoo Finance: Sector Financial Stocks Edge Higher
• Negative Sentiment: Multiple plaintiff law firms (Faruqi & Faruqi, Schall, Rosen, Gross, Bronstein Gewirtz & Grossman, DJS and others) issued notices about a securities class action tied to alleged misstatements during a May 1, 2025–Feb 27, 2026 class period; the May 19, 2026 lead‑plaintiff deadline increases near‑term legal uncertainty and potential costs. Representative firm notice: Faruqi & Faruqi: HTGC Investor Deadline Approaching
• Negative Sentiment: Hagens Berman and media reports (Hunterbrook Media) allege issues with Hercules’ deal sourcing and raise questions about disclosures—these allegations are cited by several law firms and are likely the biggest immediate driver of selling pressure. GlobeNewswire/Hagens Berman: HTGC Facing Securities Class Action

About Hercules Capital

Hercules Capital, Inc is a specialty finance company organized as a business development company (BDC) that provides tailored debt financing solutions to high‐growth companies. Through its external management structure, Hercules Capital extends senior secured loans, subordinated debt and growth capital designed to support research and development, expansion initiatives and working capital needs. The firm primarily partners with venture capital and private equity sponsors to finance innovative enterprises across various developmental stages.

The company's investment portfolio is concentrated in technology, life sciences and sustainable and renewable technology sectors, reflecting its focus on industries with strong growth prospects and recurring capital requirements.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.